Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADC3680B in atopic asthma
NCT01448954Phase 2Completed
- Sponsor
- Pulmagen Therapeutics
- Start
- Sep 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GB001, sponsored by Pulmagen Therapeutics. Started Sep 2011; status: completed.
02
Drugs
GB001
Beyond the preview
Go deeper on NCT01448954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448954.